Literature DB >> 14747394

The relationship between systemic and whole-body hematocrit is not constant during ultrafiltration on hemodialysis.

Sandip Mitra1, Paul Chamney, Roger Greenwood, Ken Farrington.   

Abstract

The measurement of relative blood volume (RBV) changes during ultrafiltration assume a constant mass and distribution of circulating blood components such as hematocrit. The authors examine the validity of this assumption in 10 subjects undergoing repeated direct measurements of systemic hematocrit and plasma volume (PV(icg)) using indocyanine green dilution at four stages of dialysis with intermittent ultrafiltration. Ultrasonic RBV changes were monitored. Absolute blood volumes (ABV) were initially derived for each PV(icg) estimate, and corresponding measured systemic hematocrit was adjusted by a factor of 0.86 to correct for the difference between the systemic and whole-body hematocrit (constant Fcell ratio). PV(icg) and ABV changes correlated closely (R = 0.98; P <0.001). ABV changes overestimated reduction in PV(icg) during ultrafiltration (mean difference, -140 +/- 202 ml). The calculated red cell mass however was variable (P <0.01). Fcell ratio was then adjusted at each blood volume measurement (Fcell(1), 0.87 +/- 0.02; Fcell(2), 0.89 +/- 0.03; Fcell(3), 0.94 +/- 0.06; Fcell(4), 0.94 +/- 0.04; P <0.01) to maintain a constant red cell mass (2146 +/- 460 ml). When ABV was recalculated using PV(icg), systemic hematocrit and variable Fcell (ABV(Fvariable)), the mean difference between PV(icg) changes and ABV(Fvariable) changes, was negligible (-0.2 +/- 35 ml). During intermittent ultrafiltration, RBV changes systematically underestimated the percentage reduction in ABV (mean difference, 7.7 +/- 10.6%). When corrected for variations in Fcell, ABV(Fvariable) and RBV differences were negligible (mean difference 1.2 +/- 2.6%). Varying Fcell ratio probably reflects microvascular volume change with net fluid shift from the microcirculation to macrocirculation (intravascular refill). This may result in underestimation of changes in systemic hematocrit and RBV during dialysis such that they were less than those predicted by directly measured changes in plasma volume.

Entities:  

Mesh:

Year:  2004        PMID: 14747394     DOI: 10.1097/01.asn.0000108970.48370.33

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  5 in total

1.  The relative trending accuracy of noninvasive continuous hemoglobin monitoring during hemodialysis in critically ill patients.

Authors:  Hiroshi Yamada; Minako Saeki; Junko Ito; Kazuhiro Kawada; Aya Higurashi; Hiromi Funakoshi; Kohji Takeda
Journal:  J Clin Monit Comput       Date:  2014-05-03       Impact factor: 2.502

2.  Pediatric intradialytic hypotension: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) Workgroup.

Authors:  Rupesh Raina; Stephanie Lam; Hershita Raheja; Vinod Krishnappa; Daljit Hothi; Andrew Davenport; Deepa Chand; Gaurav Kapur; Franz Schaefer; Sidharth Kumar Sethi; Mignon McCulloch; Arvind Bagga; Timothy Bunchman; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2019-02-08       Impact factor: 3.714

3.  Red blood cell (RBC) volume can be independently determined in vivo in humans using RBCs labeled at different densities of biotin.

Authors:  Donald M Mock; Nell I Matthews; Shan Zhu; Leon F Burmeister; M Bridget Zimmerman; Ronald G Strauss; Robert L Schmidt; Demet Nalbant; Gretchen A Cress; John A Widness
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

4.  Concordance of absolute and relative plasma volume changes and stability of Fcells in routine hemodialysis.

Authors:  Daniel Schneditz; Werner Ribitsch; Gernot Schilcher; Matthias Uhlmann; Yossi Chait; Vanessa Stadlbauer
Journal:  Hemodial Int       Date:  2015-08-05       Impact factor: 1.812

5.  Hemodialysis-induced changes in hematocrit, hemoglobin and total protein: Implications for relative blood volume monitoring.

Authors:  Leszek Pstras; Malgorzata Debowska; Alicja Wojcik-Zaluska; Wojciech Zaluska; Jacek Waniewski
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.